Background Remote ischemic preconditioning (RIPC) is reported to reduce biomarkers of
ischemic and reperfusion injury in patients undergoing cardiac surgery, but uncertainty about …

Background Multiple major health organisations recommend the use of extracorporeal
membrane oxygenation (ECMO) support for COVID-19-related acute hypoxaemic respiratory …

Importance Blood transfusion is one of the most frequently used therapies worldwide and is
associated with benefits, risks, and costs. Objective To develop a set of evidence-based …

Background Ivermectin, an antiparasitic agent used to treat parasitic infestations, inhibits the
replication of viruses in vitro. The molecular hypothesis of ivermectin's antiviral mode of …

Background The role of vitamin D supplementation as a treatment for COVID‐19 has been a
subject of considerable discussion. A thorough understanding of the current evidence …

Importance Tranexamic acid (TXA) is an efficient antifibrinolytic agent; however, concerns
remain about the potential adverse effects, particularly vascular occlusive events, that may be …

Objectives: To determine whether a multidisciplinary, multimodal Patient Blood Management
(PBM) program for patients undergoing surgery is effective in reducing perioperative …

Importance High-dose intravenous administration of sodium selenite has been proposed to
improve outcome in sepsis by attenuating oxidative stress. Procalcitonin-guided …

More than 30% of the world's population are anemic with serious economic consequences
including reduced work capacity and other obstacles to national welfare and development. …

Objective: To determine whether the implementation of patient blood management (PBM) is
effective to decrease the use of red blood cell without impairment of patient's safety. …